Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Genitourinary 2Other solid neoplasm 1Gynecologic 1Breast 1

Conditions

Testicular Neoplasms 2Thymoma 1Teratoma 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
isophosphamide mustard × Genitourinary × Clear all
NCT01808534 2015-07-02

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

Indiana University

Phase 2 Terminated
5 enrolled 11 charts
Genitourinary

Teratoma, Testicular Neoplasms

NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡